Inspire Advisors, LLC Edwards Lifesciences Corp Transaction History

Inspire Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$61.71 - $77.76 $67,881 - $85,536	-1,100 Reduced 13.99%	6,763 $515,000
Q3 2023 Oct 26, 2023	BUY	$69.28 - $93.38 $544,748 - $734,246	7,863 New	7,863 $544,000
Q2 2022 Aug 10, 2022	SELL	$86.5 - $128.27 $390,374 - $578,882	-4,513 Closed	0 $0
Q1 2022 Apr 21, 2022	BUY	$101.96 - $128.34 $185,873 - $233,963	1,823 Added 67.77%	4,513 $531,000
Q4 2021 Feb 03, 2022	BUY	$106.37 - $130.68 $286,135 - $351,529	2,690 New	2,690 $349,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Inspire Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Inspire Advisors, LLC with notifications on news.